Simplify Logo

Full-Time

Senior Validation Engineer

Confirmed live in the last 24 hours

Project Farma

Project Farma

51-200 employees

Biomanufacturing services for cell and gene therapy

Consulting
Biotechnology

Compensation Overview

$60k - $75kAnnually

+ Bonus

Junior

Philadelphia, PA, USA

Full-time on-site client presence required.

Category
QA & Testing
Manual Testing
Quality Assurance
Requirements
  • Bachelor’s degree in Life Science, Engineering, or related discipline and/or comparable military experience.
  • A minimum of 1 year of Project Engineer, Consulting, and/or relevant industry experience.
  • Covid Vaccine is required prior to the Team Member’s start date with exceptions for medical and religious accommodations when reasonable.
  • Full time on-site client presence
  • Willingness to travel up to 100% or as required to support project and business needs.
Responsibilities
  • Create alignment with cross-functional client departments including but not limited to Validation, Manufacturing, Quality, Supply Chain, and Engineering.
  • Provide hands-on support and troubleshooting for clients navigating the engineering life cycle of cutting-edge equipment and manufacturing processes.
  • Perform due diligence on system and subject domains to generate high-quality project deliverables.
  • Author technical documents such as SOPs, requirements specifications, testing protocols, summary reports, etc.
  • Execute system and process validation protocols using GxP best practices.
  • Proactively identify and escalate roadblocks and utilize critical thinking skills and knowledge of problem-solving skills to identify creative solutions to those problems and roadblocks.
  • Contribute to and embody our Patient Focused and People First Mission through the involvement in professional development and philanthropic opportunities.
  • Build meaningful internal and external relationships presenting Project Farma as a service to clients as needed.

Project Farma specializes in biomanufacturing, focusing on cell and gene therapy. They develop and implement strategies for advanced therapy facilities, helping clients create treatments that modify genes to address diseases. Their services encompass the entire lifecycle of biomanufacturing projects, including facility construction, validation, quality assurance, regulatory compliance, and automation. Project Farma distinguishes itself by offering comprehensive, turnkey solutions that ensure facilities meet Good Manufacturing Practices (GMP), which is essential for producing safe therapies. Their goal is to enhance patient outcomes through effective project execution and they also emphasize philanthropy and professional development within their team.

Company Stage

Acquired

Total Funding

N/A

Headquarters

Chicago, Illinois

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition by Precision Medicine Group could provide additional resources and market reach, enhancing Project Farma's service offerings.
  • Their comprehensive service model covering the entire lifecycle of biomanufacturing projects offers employees diverse opportunities for skill development.
  • Strong philanthropic initiatives and a focus on professional development create a fulfilling work environment.

What critics are saying

  • The niche focus on cell and gene therapy could limit market opportunities compared to broader biomanufacturing services.
  • Integration challenges post-acquisition by Precision Medicine Group could lead to operational disruptions.

What makes Project Farma unique

  • Project Farma specializes in the cell and gene therapy market, offering end-to-end biomanufacturing solutions, unlike competitors who may focus on broader pharmaceutical services.
  • Their turnkey solutions ensure GMP compliance from initial planning to final execution, providing a seamless experience for clients.
  • A strong focus on philanthropy and professional development, such as the PF Cares Weekend, sets them apart in terms of corporate culture and employee engagement.